Page 4,806«..1020..4,8054,8064,8074,808..4,8204,830..»

How to Improve Acute Stroke Care – Video

Posted: Published on November 1st, 2013

How to Improve Acute Stroke Care Finland is one of the world's leading nations in the field of acute stroke care. In this film, Professor Markku Kaste from Helsinki University Hospital expla... By: Siemens … Continue reading

Comments Off on How to Improve Acute Stroke Care – Video

New drug to relieve Parkinson's psychosis: Breakthrough could offer better quality of life for thousands who suffer …

Posted: Published on November 1st, 2013

Existing anti-psychotic drugs can make symptoms worse By Jenny Hope PUBLISHED: 21:04 EST, 31 October 2013 | UPDATED: 21:04 EST, 31 October 2013 Hope: The first treatment for hallucinations and delusions has been developed which dramatically improves sufferers' symptoms and quality of life A new drug offers hope for tens of thousands of sufferers of Parkinsons, say researchers. The first treatment for hallucinations and delusions has been developed which dramatically improves symptoms and quality of life. Half of those with the degenerative brain disorder experience such symptoms but existing antipsychotic drugs can make them worse, increase the risk of stroke and be life-threatening. The new drug called pimavanserin proved safe and effective in a trial of almost 200 patients, leading to improvements of more than a third in sufferers. The drug also has potential for treating psychotic symptoms in diseases such as Alzheimers and other dementias. Study leader Professor Clive Ballard from Kings College London said: Psychotic symptoms are common and distressing for people with Parkinsons and those caring for them. Original post: New drug to relieve Parkinson's psychosis: Breakthrough could offer better quality of life for thousands who suffer ... … Continue reading

Posted in Parkinson's Treatment | Comments Off on New drug to relieve Parkinson's psychosis: Breakthrough could offer better quality of life for thousands who suffer …

New drug may provide first safe, effective treatment for psychotic symptoms

Posted: Published on November 1st, 2013

For many patients suffering from Parkinsons disease, tremors and loss of movement arent the only symptoms they have to cope with. In more than half of cases, people are also plagued with distressing symptoms of psychosis, which often include visual hallucinations and paranoid thoughts. While numerous effective treatments exist for the motor problems associated with Parkinsons, current treatment options for psychotic symptoms are either ineffective or potentially harmful. And some form of treatment is definitely needed - psychosis is considered to be the main reason why people with the disease are admitted to nursing homes, and also significantly increases a patients risk for early death. To address this problem, researchers from Kings College London have identified a pre-existing drug that may effectively control the psychotic symptoms stemming from Parkinsons disease. Known as pimavanserin, the drug works by blocking serotonin 5-HT2A receptors in the neocortex, which had been previously associated with visual hallucinations. In the majority of (Parkinsons patients), lots of chemical transmitters in the brain are imbalanced, study author Clive Ballard, professor of age-related diseases at Kings College, told FoxNews.com. But the 5-HT system, that chemical system is quite imbalanced and strongly associated with the presence of these symptoms. So … Continue reading

Posted in Parkinson's Treatment | Comments Off on New drug may provide first safe, effective treatment for psychotic symptoms

New drug 'safe and effective' for Parkinson's psychosis

Posted: Published on November 1st, 2013

Current ratings for: New drug 'safe and effective' for Parkinson's psychosis Ratings require JavaScript to be enabled. Researchers say that a new non-dopaminergic drug called pimavanserin may be the first to offer safe and effective treatment for patients who experience psychotic symptoms associated with Parkinson's disease. This is according to a new study published in The Lancet. According to the research team from the US and UK, of the 10 million people worldwide who have Parkinson's disease, more than 50% of them can experience psychosis, mainly in the form of hallucinations and delusions. "Psychotic symptoms are common and distressing for people with Parkinson's and those caring for them," says Prof. Clive Ballard of King's College London and study leader. "Psychosis is a major driving factor for people with Parkinson's disease being admitted to nursing homes and substantially increases the risk of dying. But no safe and effective drug therapies exist." At present, Parkinson's patients who suffer with psychosis only have the choice of antipsychotic drugs - such as clozapine and quetiapine - as a form of treatment for psychosis. But Prof. Ballard says that these drugs may worsen motor symptoms of Parkinson's, speed up cognitive decline and can be life-threatening … Continue reading

Posted in Parkinson's Treatment | Comments Off on New drug 'safe and effective' for Parkinson's psychosis

Young Athletes' Concussions Often Unreported: Report

Posted: Published on November 1st, 2013

By Steven Reinberg HealthDay Reporter WEDNESDAY, Oct. 30 (HealthDay News) -- A "culture of resistance" pervasive in many youth sports often keeps athletes from reporting concussions and obtaining needed treatment, a new U.S. report finds. This culture persists despite a growing understanding that all concussions cause some degree of brain injury, according to the report released Wednesday by the Institute of Medicine (IOM). "We know that concussions are frequent and potentially serious," said IOM committee vice-chair Dr. Frederick Rivara, a professor of pediatrics at the University of Washington School of Medicine in Seattle. Reviewing data on concussions suffered by 5- to 21-year-olds, the committee of independent experts found that reported concussion rates are higher among high school athletes than college players in sports such as football, men's lacrosse, soccer and baseball. And despite marketing hype, the committee found that current helmet designs provide little protection from concussions. Tracey Covassin, an assistant professor of kinesiology at Michigan State University in East Lansing, said concussions may go unreported for a variety of reasons. "There are still coaches and parents that think kids need to tough it out and continue to play, or if they don't tell anyone it will go away," said … Continue reading

Posted in Brain Injury Treatment | Comments Off on Young Athletes' Concussions Often Unreported: Report

ViroPharma Beats by a Penny

Posted: Published on November 1st, 2013

ViroPharma Inc. (VPHM) reported a net income of 7 cents in the third quarter of 2013, beating the Zacks Consensus Estimate by a penny. The company reported a loss of 3 cents per share in the year-ago quarter. Quarterly revenues increased 24.2% year over year to $113.1 million, in line with the Zacks Consensus Estimate. The year-over-year growth in revenues was fuelled by strong growth of Cinryze in the U.S. Quarterly Highlights Cinryze sales increased 25% from the prior-year quarter to $107.0 million during the third quarter of 2013, driven by higher patient demand. Net sales in the US grew by 22% to $102.2 million. Sales from Europe came in at $10 million. Research and development (R&D) expenses increased 9.3% during the quarter to $18.1 million. Selling, general and administrative (SG&A) expenses amounted to $45.5 million, up 2.7% year over year. 2013 Outlook Updated ViroPharma updated its guidance for 2013. The company now expects net product sales in the range of $445 million $465 million compared to the previous estimate of $440 million - $465 million. The Zacks Consensus Estimate of $446 million is towards the lower end of the companys guidance range. The company now projects Cinryze sales of … Continue reading

Comments Off on ViroPharma Beats by a Penny

Hormone replacement therapy (male-to-female) – Wikipedia, the free …

Posted: Published on November 1st, 2013

Hormone replacement therapy (HRT) for transgender and transsexual people changes the balance of sex hormones in their bodies. Some intersex people also receive HRT, either starting in childhood to confirm the sex to which they were assigned, or later, if this assignment has proven to be incorrect. Its purpose is to cause the development of the secondary sex characteristics of the desired sex. It cannot undo many of the changes produced by the first natural occurring puberty, which may necessitate surgery and/or epilation (see below). The requirements for hormone replacement therapy vary immensely, often at least a certain time of psychological counseling is required. Some organizations still require a period of time living as the desired gender role, based on standards such as the Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People. This period is sometimes called the Real Life Experience (RLE). Some people, especially individuals from the transgender community, say that RLE is psychologically harmful and is a form of "gatekeeping" effectively barring the person from transitioning for as long as possible, if not permanently.[who?] Some individuals choose to self-administer their medication ("do-it-yourself"), often because available doctors have too little experience in this matter, … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormone replacement therapy (male-to-female) – Wikipedia, the free …

Hormone replacement therapy (menopause) – Wikipedia, the free …

Posted: Published on November 1st, 2013

Hormone replacement therapy (HRT) in menopause is medical treatment in surgically menopausal, perimenopausal and postmenopausal women. Its goal is to mitigate discomfort caused by diminished circulating estrogen and progesterone hormones in menopause. Combination HRT is often recommended as it decreases the amount of endometrial hyperplasia and cancer associated with unopposed estrogen therapy.[1][2] The main hormones involved are estrogen, progesterone and progestin. Some recent therapies include the use of androgens as well.[3] The 2002 Women's Health Initiative of the National Institutes of Health found disparate results for all cause mortality with hormone replacement, finding it to be lower when HRT was begun earlier, between age 50-59, but higher when begun after age 60. In older patients, there was an increased incidence of breast cancer, heart attacks and stroke, although a reduced incidence of colorectal cancer and bone fracture.[4] Some of the WHI findings were again found in a larger national study done in the UK, known as The Million Women Study. As a result of these findings, the number of women taking hormone treatment dropped precipitously.[5] The Women's Health Initiative recommended that women with non-surgical menopause take the lowest feasible dose of HRT for the shortest possible time to minimize associated … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormone replacement therapy (menopause) – Wikipedia, the free …

Hormone Therapy Uses, Side Effects, Types – MedicineNet

Posted: Published on November 1st, 2013

Menopause Symptoms Medical Author: Melissa Conrad Stppler, MD Medical Editor: William C. Shiel Jr., MD, FACP, FACR Some of the symptoms of menopause can actually begin years before menstrual periods stop occurring. Doctors generally use the term "perimenopause" to refer to the time period beginning prior to the menopause (when some of the signs and symptoms of menopause begin to occur) up through the first year following menopause. Menopause itself is defined as having had 12 consecutive months without a menstrual period. Menopause symptoms begin gradually while the ovaries are still functioning and a woman is still having menstrual periods. These symptoms can begin as early as the 4th decade of life (when a woman is in her 30s) and may persist for years until menopause has occurred. The symptoms occur early because the levels of hormones produced by the ovaries (estrogen and progesterone) decline slowly over time, explaining why pregnancy is still possible, but less likely to occur, as a woman reaches her forties. The severity and duration of symptoms vary widely among individuals - some women may experience only minimal symptoms for a year or two, while others may experience at least some of the symptoms for several … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormone Therapy Uses, Side Effects, Types – MedicineNet

Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy

Posted: Published on November 1st, 2013

ANN ARBOR, Mich., Nov. 1, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that results from two separate research studies involving ixmyelocel-T, the company's lead product candidate, were published in the peer reviewed journal Stem Cell Research & Therapy. Results from the first study, "Ixmyelocel-T, an Expanded Multicellular Therapy, Contains a Unique Population of M2-Like Macrophages", show that ixmyelocel-T contains M2-like macrophages characterized by expression of multiple, well-known M2 macrophage markers, decreased secretion of pro-inflammatory cytokines after inflammatory stimuli, and efficient removal of apoptotic cells. The population of macrophages generated in ixmyelocel-T is believed to play a role in tissue repair and regeneration. "Our data demonstrate that ixmyelocel-T therapy contains a unique population of M2-like macrophages characterized by secretion of anti-inflammatory cytokines and expression of M2 markers CD206 and CD163. In addition to being involved in efficient removal of apoptotic cells, they also show elevated expression of MerTK, which is essential in limiting tissue injury and promoting repair. These findings provide further indication that these cells may play a key role in the treatment of diseases where tissue remodeling and immunomodulation are … Continue reading

Posted in Stem Cell Research | Comments Off on Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy

Page 4,806«..1020..4,8054,8064,8074,808..4,8204,830..»